Nearly 80% of autoimmune disease diagnoses are in women. That's not a minor skew, it's one of the most consistent patterns in all of immunology, and it shows up across wildly different conditions: lupus (as high as 9-to-1 female-to-male), Sjögren's syndrome, autoimmune thyroid disease, multiple sclerosis, rheumatoid arthritis, myasthenia gravis. Whatever is driving this, it isn't specific to one disease. It's something more fundamental about being female.
There are four separate, overlapping theories, each with real evidence behind it. None of them fully explains the pattern on its own. Together, they start to make sense.
Estrogen doesn't just affect reproduction, it acts directly on immune cells. It can boost antibody production, influence how T and B cells mature and activate, and shape the intensity of the whole immune response. In general, women mount stronger immune responses than men do, which is part of why women tend to fight off infections more effectively and respond more robustly to vaccines. But that same heightened responsiveness comes at a cost: a more reactive immune system is also a system more prone to attacking the body's own tissue.
The catch is that estrogen's effect isn't simply "more estrogen, more autoimmune risk." Its impact depends heavily on the specific disease. In lupus, estrogen tends to be associated with disease flares. In multiple sclerosis, it appears to have the opposite, protective effect. Researchers describe this as estrogen acting through multiple receptor types and signaling pathways that behave differently depending on the tissue and the disease, which is why autoimmune conditions often flare or improve at very specific hormonal moments: pregnancy, postpartum, and perimenopause all show up repeatedly as high-risk windows across different autoimmune diseases.
Every cell in a woman's body carries two X chromosomes, but only one is ever "switched on" per cell, the other gets silenced early in embryonic development, in a process called X-chromosome inactivation. Which X gets silenced is random, cell by cell, so a woman ends up as a mosaic: roughly half her cells running on her mother's X, half on her father's.
Here's the important part: that silencing isn't perfect. Somewhere between 15% and 23% of genes on the "inactive" X chromosome still leak some expression, including several genes with direct roles in immune signaling, like TLR7, a gene involved in recognizing viral genetic material. When TLR7 gets expressed from both X chromosomes instead of being properly dosed down to one, immune cells can become primed to overreact to the body's own nucleic acids. In mouse studies, disrupting the normal silencing process was enough to trigger lupus-like disease, autoantibodies, an enlarged spleen, and inflammatory immune cell activity, in female mice specifically. Men, with only one X chromosome to begin with, don't have this dosage problem at all.
This mechanism has been tied specifically to skewed X-inactivation patterns in scleroderma, autoimmune thyroid disease, and myasthenia gravis, giving it real disease-specific evidence rather than just theoretical plausibility.
.png)
During pregnancy, cells cross the placenta in both directions, some of the baby's cells end up circulating in the mother, and some of the mother's cells end up in the baby. That exchange doesn't fully clear after birth. Small numbers of these foreign cells, fetal cells in the mother, in this case, can persist for decades, quietly living on in her blood and tissues. This is called fetal microchimerism, and it's been detected in maternal tissue many years, even decades, after delivery.
For most women, this seems to be biologically neutral or even mildly beneficial, a possible source of tissue repair cells, for instance. But in a subset of women, these long-lived foreign cells appear to provoke a low-grade immune reaction that looks a lot like a mild, chronic version of graft-versus-host disease, the same phenomenon seen after bone marrow transplants, when a donor's immune cells recognize the recipient's body as foreign. Researchers have found these fetal cells at meaningfully higher rates in women with scleroderma and autoimmune thyroid disease compared to women who've never been pregnant, and the effect appears cumulative, more pregnancies, more opportunity for this kind of chimerism to build up.
Women are disproportionately iron deficient to begin with, largely due to menstrual blood loss: globally, close to 30% of reproductive-age women are anemic. Separately, a large cohort study found that women newly diagnosed with iron deficiency anemia had more than double the risk of later developing an autoimmune disease, and that elevated risk was specifically pronounced in women. The proposed mechanism is that iron deficiency impairs how the body clears damaged cells, and that leftover cellular debris can become a trigger for autoimmune activity.
The evidence here is more mixed than the hormone or X-chromosome research, some of the relationship almost certainly runs the other way, with autoimmune disease and inflammation causing the iron deficiency rather than the reverse. But even as a contributing factor layered on top of hormonal and genetic risk, it's a meaningfully underappreciated one, and it happens to be one of the few pieces on this list that's actually monitorable and modifiable.
.png)
None of these four mechanisms is something a patient can control, and three of the four aren't things a single office visit every few months is well positioned to catch early. They involve physiology unfolding over months or years rather than symptoms that appear in a single encounter. But they all point toward the same practical conclusion: women with autoimmune conditions, or elevated risk for one, benefit from care that pays attention continuously, not episodically. Iron status can be tracked. Symptom flares tied to hormonal windows like postpartum or perimenopause can be caught early instead of dismissed as unrelated. Patterns that would never surface in a 15-minute visit have room to show up when someone is actually watching in between appointments.
That continuous layer of attention, not replacing the physician relationship, but filling the gap between visits, is exactly what Besti Health is built to provide for women managing chronic and autoimmune conditions.
Sources used:
1. Sciarra, F. et al. "The Estrogen-Immunity Enigma." Rupa Health, 2025. https://www.rupahealth.com/post/the-estrogen-immunity-enigma-exploring-womens-resilience-and-vulnerability
2. Khan, D. & Ansar Ahmed, S. "Sex Hormones in Acquired Immunity and Autoimmune Disease." Frontiers in Immunology, 2018. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.02279/full
3. "New findings link estrogen and T cell immune response to autoimmune inflammation." ScienceDaily, University of Turku research. https://www.sciencedaily.com/releases/2018/05/180531131116.htm
4. Dai, R. & Ahmed, S.A. "Sexual Dimorphism of miRNA Expression..." / related: "Altered X-chromosome inactivation predisposes to autoimmunity." PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11068014/
5. "New Evidence of X-Chromosome's Role in Autoimmune Disease in Women." Inside Precision Medicine, 2024. https://www.insideprecisionmedicine.com/topics/precision-medicine/new-evidence-of-x-chromosomes-role-in-autoimmune-disease-in-women/
6. "Escape from X Chromosome Inactivation and the Female Predominance in Autoimmune Diseases." International Journal of Molecular Sciences (MDPI), 2021. https://www.mdpi.com/1422-0067/22/3/1114
7. "Gender bias in autoimmune diseases: X chromosome inactivation in women with multiple sclerosis." Journal of Neurological Sciences, ScienceDirect. https://www.sciencedirect.com/science/article/abs/pii/S0022510X09005681
8. "Microchimerism." ScienceDirect Topics overview. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/microchimerism
9. "Autoimmune disease during pregnancy and the microchimerism legacy of pregnancy." PubMed. https://pubmed.ncbi.nlm.nih.gov/18716941/
10. "Fetal Microchimeric Cells in Blood of Women with an Autoimmune Thyroid Disease." PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246474/
11. "Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus." PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835618/
12. Chen, Y-C. et al. Taiwan IDA/autoimmune cohort study (from the earlier iron research). https://www.tandfonline.com/doi/full/10.1080/03007995.2020.1748585
13. "Iron: Not Just a Passive Bystander in AITD." PMC, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9658435/